Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-21
2011-10-04
Kosar, Andrew D (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S361100, C548S361500
Reexamination Certificate
active
08030340
ABSTRACT:
Compounds of formula (I):or a pharmaceutically acceptable salt thereof, compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal).
REFERENCES:
patent: 3992441 (1976-11-01), Helland
patent: 4443477 (1984-04-01), Witte et al.
patent: 4948809 (1990-08-01), Witte et al.
patent: 5861401 (1999-01-01), Bradbury
patent: 6323199 (2001-11-01), Lehmann et al.
patent: 7297709 (2007-11-01), Dai et al.
patent: 2004/0235892 (2004-11-01), Dai et al.
patent: 2007/0265326 (2007-11-01), Biggadike et al.
patent: 2008/0207721 (2008-08-01), Berger et al.
patent: 2008/0214641 (2008-09-01), Berger et al.
patent: 2009/0093485 (2009-04-01), Bladh et al.
patent: 2009/0124607 (2009-05-01), Bladh et al.
patent: 2009/0170898 (2009-07-01), Bengtsson et al.
patent: 0031954 (1981-07-01), None
patent: 0201735 (1986-11-01), None
patent: 0261539 (1988-03-01), None
patent: 0558258 (1993-09-01), None
patent: 0569193 (1993-11-01), None
patent: 0610896 (1994-08-01), None
patent: 0679641 (1995-11-01), None
patent: 0947500 (1999-10-01), None
patent: 0976722 (2000-02-01), None
patent: 1190710 (2002-03-01), None
patent: 1447401 (2004-08-01), None
patent: 0607840.6 (2006-04-01), None
patent: WO95/02580 (1995-01-01), None
patent: WO95/03279 (1995-02-01), None
patent: WO95/33461 (1995-12-01), None
patent: WO96/06822 (1996-03-01), None
patent: WO96/36595 (1996-11-01), None
patent: WO99/33786 (1999-07-01), None
patent: WO99/38845 (1999-08-01), None
patent: WO01/24786 (2001-04-01), None
patent: WO01/46172 (2001-06-01), None
patent: WO02/20474 (2002-03-01), None
patent: WO02/28820 (2002-04-01), None
patent: WO03/028641 (2003-04-01), None
patent: WO03/076401 (2003-09-01), None
patent: WO03/086294 (2003-11-01), None
patent: WO03/099773 (2003-12-01), None
patent: WO2004/018414 (2004-03-01), None
patent: WO2004/019935 (2004-03-01), None
patent: WO2004/050631 (2004-06-01), None
patent: WO2004/073634 (2004-09-01), None
patent: WO2004/089913 (2004-10-01), None
patent: WO2004/110418 (2004-12-01), None
patent: WO2005/004810 (2005-01-01), None
patent: WO2005/060963 (2005-07-01), None
patent: WO2005/077895 (2005-08-01), None
patent: WO2005/086904 (2005-09-01), None
patent: WO2005/123688 (2005-12-01), None
patent: WO2006/046914 (2006-05-01), None
patent: WO2006/046916 (2006-05-01), None
patent: WO2006/135826 (2006-12-01), None
patent: WO2006/138373 (2006-12-01), None
patent: WO 2007/046747 (2007-04-01), None
patent: WO2007/054294 (2007-05-01), None
patent: WO2007/114763 (2007-10-01), None
patent: WO2007/122165 (2007-11-01), None
patent: WO2008/008882 (2008-01-01), None
patent: WO2008/043788 (2008-04-01), None
patent: WO2008/043789 (2008-04-01), None
patent: WO2008/051532 (2008-05-01), None
patent: WO2008/057856 (2008-05-01), None
patent: WO2008/057857 (2008-05-01), None
patent: WO2008/063116 (2008-05-01), None
patent: WO2008/070507 (2008-06-01), None
patent: WO2008/076048 (2008-06-01), None
patent: WO2008/079073 (2008-07-01), None
patent: WO2008/124665 (2008-10-01), None
patent: WO2008/124745 (2008-10-01), None
patent: WO2008/135578 (2008-11-01), None
patent: WO2009/050218 (2009-04-01), None
patent: WO2009/050220 (2009-04-01), None
patent: WO2009/050221 (2009-04-01), None
patent: WO2009/050243 (2009-04-01), None
patent: WO2009/050244 (2009-04-01), None
patent: WO2009/062950 (2009-05-01), None
patent: WO2009/074590 (2009-06-01), None
patent: WO2009/108525 (2009-09-01), None
patent: WO2009/111214 (2009-09-01), None
Bradbury et al., “New Non-Peptide Endothelin-A Receptor Antagonists: Synthesis, Biological Properties, and Structure-Activity Relationships of 5-(Dimethylamino)-N-pyridyl-, -N-pyrimidinyl-N-pyridazinyl-, and -N-pyrazinyl-1-naphthalenesulfonamides”,J. Med. Chem. 40:996-1004 (1997).
Fabiana et al., “Mode of Action of Sulfanilyl Fluoroquinolones”,Antimicrobial Agents and Chemotherapy42:1495-1498 (1998).
Gaedcke et al., “Structure dependence of antiplasmodic activity of 3-IN-(4′-amidosulphonylphenypamin˜methyl] quinoline”,Arch. Pharm(Weinheim) 313:166-173 (1930).
Jansen et al., “Hydantoin-Substituted 4,6-Dichloroindole-2-carboxylic Acids as Ligands with High Affinity for the Glycine Building Site of the NMDA Receptor”,J. Med. Chem. 46:64-73 (2003).
STN International file Registry: RN 321722-44-5, RN 321704-10-3, RN 321704-02-3, RN 321703-82-6, RN 321703-77-9, RN 321703-75-7.
STN International file Registry: RN 674768-65-1, RN 343372-84-9, RN 343372-70-3, RN 339016-98-7, RN 519018-69-0, RN 261623-54-5.
Clark et al., “1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity”,Bioorg. Med. Chem. Lett. 18:1312-1317 (2008).
Mohler et al., “Dissociated non-steroidal glucocorticoids: tuning out untoward effects”,Expert Opin. Ther. Patents17:37-58 (2007).
Mohler et al., “Non-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti- glucocorticoid therapy”,Expert Opin. Ther. Patents17:59-81 (2007).
Schäcke et al., “Dissociated non-steroidal glucocorticoid receptor modulators: an update on new compounds”,Expert Opin. Ther. Patents18:339-352 (2008).
USPTO Notice of Allowance in U.S. Appl. No. 12/005,066, mailed Mar. 24, 2009, 10 pages.
Fish & Richardson P.C., Request for Continued Examination in U.S. Appl. No. 12/005,066, filed Jun. 19, 2009, 6 pages.
USPTO Notice of Allowance in U.S. Appl. No. 12/005,066, mailed Sep. 9, 2009, 6 pages.
Fish & Richardson P.C., Request for Continued Examination in U.S. Appl. No. 12/005,066, filed Nov. 10, 2009, 5 pages.
USPTO Notice of Allowance in U.S. Appl. No. 12/005,066, mailed Jan. 13, 2010, 8 pages.
Berger Markus
Bergstrom Lena
Dahmen Jan
Eriksson Anders
Gabos Balint
AstraZeneca AB
Bayer Schering Pharma Aktiengesellschaft
Fish & Richardson P.C.
Kosar Andrew D
Rodriguez-Garcia Valerie
LandOfFree
Indazolyl sulphonamide derivatives useful as glucocorticoid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazolyl sulphonamide derivatives useful as glucocorticoid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazolyl sulphonamide derivatives useful as glucocorticoid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4273592